Gelonghui, March 4, 丨 Kehua Biotech (002022.SZ) announced that recently, Shanghai Kehua Bioengineering Co., Ltd. received the “Medical Device Registration Certificate” (in vitro diagnostic reagent) issued by the Shanghai Drug Administration. Kit for determination of total protein in cerebrospinal fluid/urine (catechol red method).
科华生物(002022.SZ)：“脑脊液/尿液总蛋白测定试剂盒(邻苯三酚红法)”获得医疗器械注册证
Kehua Biology (002022.SZ): “Cerebrospinal Fluid/Urine Total Protein Determination Kit (Catechol Red Method)” obtained a medical device registration certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.